HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study of renovascular hypertension in rat. II. Effects of converting enzyme inhibitor (captopril) in the acute and chronic stages of two-kidney one-clip Goldblatt hypertension in rat.

Abstract
Two-kidney, one-clip Goldblatt models were produced in Wistar rats by placing a stenotic clip around the left renal artery. The animals were classified into three groups according to the time when captopril was started. In group 1 rats captopril was begun on the day following the operation and was continued for 6 weeks. During this period hypertension did not develop. In group 2 in which captopril was started 4 weeks after placement of the renal arterial clip, the blood pressure remained high as late as 12 weeks despite of continued administration of the drug. However, in group 3, captopril which was started 12 weeks postoperatively was very effective in correcting high blood pressure. In the sham operated group the blood pressure was unchanged by captopril administration. These results suggest that the role of renin-angiotensin system seems to vary according to the stages of experimental hypertension and that at least in the acute and chronic stage of two-kidney one-clip Goldblatt hypertension angiotensin II may play a major role in initiation and maintenance of high blood pressure.
AuthorsK Matsushita
JournalThe Tokai journal of experimental and clinical medicine (Tokai J Exp Clin Med) Vol. 10 Issue 1 Pg. 31-6 (Apr 1985) ISSN: 0385-0005 [Print] Japan
PMID3913058 (Publication Type: Journal Article)
Chemical References
  • Captopril
Topics
  • Acute Disease
  • Animals
  • Blood Pressure (drug effects)
  • Captopril (pharmacology)
  • Chronic Disease
  • Hypertension, Renovascular (drug therapy, physiopathology)
  • Kidney (physiopathology)
  • Rats
  • Rats, Inbred Strains
  • Renin-Angiotensin System (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: